Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 1 - 5 out of 312
Li, E, Boujeddaine, N, Houtman, MJC, Maas, Sluijter, , Ecker, G, Weinzinger, A, van Ham, W & van der Heyden, M 2024, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology. <https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.17377>
Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599
Granulo, N, Sosnin, S, Digles, D & Ecker, GF 2024, 'The macrocycle inhibitor landscape of SLC‐transporter', Molecular Informatics, vol. 43, no. 5, e202300287. https://doi.org/10.1002/minf.202300287
Huang, J, Osthushenrich, T, MacNamara, A, Mälarstig, A, Brocchetti, S, Bradberry, S, Scarabottolo, L, Ferrada, E, Sosnin, S, Digles, D, Superti-Furga, G & Ecker, GF 2024, 'ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction', Rsc advances, vol. 14, no. 19, 00748, pp. 13083-13094. https://doi.org/10.1039/d4ra00748d
Ferrada, E, Wiedmer, T, Wang, WA, Frommelt, F, Steurer, B, Klimek, C, Lindinger, S, Osthushenrich, T, Garofoli, A, Brocchetti, S, Bradberry, S, Huang, J, MacNamara, A, Scarabottolo, L, Ecker, GF, Malarstig, A & Superti-Furga, G 2024, 'Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8', Journal of Molecular Biology, vol. 436, no. 2, 168383. https://doi.org/10.1016/j.jmb.2023.168383
Activities
Showing entries 131 - 135 out of 202
Synthesis of subtype selective ligands for ?5 containing GABAA/BZ receptors to treat memory deficits
T Clayton
,
Margot Ernst
,
Lars Richter
,
S Sanker
,
Timothy M. DeLorey
,
Werner Sieghart
,
R Furtmüller
,
Gerhard Ecker
,
J M Cook
238th American Chemical Society National Meeting & Exposition
Conference,
Poster presentation
..2009 - ..2009
Synthesis, spasmolytic activity and structure-activity relationship studies of a series of thiobenzanilides
Christian Studenik
,
Thomas Erker
,
Gerda Brunhofer-Bolzer
,
Gerhard Ecker
Nicht angegeben
Other,
Poster presentation
..2009 - ..2009
Using multiple approaches in docking pose evaluation application to the GABA-A receptor
Lars Richter
,
Margot Ernst
,
Werner Sieghart
,
Gerhard Ecker
21. Wissenschaftliche Tagung der Österreichischen Pharmazeutischen Gesellschaft
Conference,
Poster presentation
..2009 - ..2009
Safety Sciences in silico - Analyse unerwünschter Wirkungen durch molekulare Modellierung
Gerhard Ecker
5. Wissenschaftliches Symposium der Österreichischen Gesellschaft für Toxikologie
Conference,
Talk or oral contribution
19.11.2008 - 19.11.2008
Optimising ligands for promiscuous targets - a case study for P-glycoprotein inhibitors
Gerhard Ecker
BIT's 6th Annual Congress of International Drug Discovery Science and Technology
Conference,
Talk or oral contribution
20.10.2008 - 20.10.2008